NewslettersImmunology of Infectious Disease NewsUncategorizedVirus Induced Lymphocytes (VIL) as a Novel Viral Antigen-Specific T Cell Therapy for COVID-19 and Potential Future PandemicsBy Justin.choi - July 28, 2021011Using a novel SARS-Cov-2-specific artificial antigen presenting cell, coupled with a rapid expansion protocol as practiced in tumor infiltrating lymphocytes therapy, researchers generated an immune catalytic quantity of VIL.[Scientific Reports] 6445218 {6445218:8Q9KPNVS} apa 50 1 165081 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article